ASCO Annual Meeting

Novel Drug-Chemo Combo Significantly Improves Survival in Rare Form of Head and Neck Cancer

June 5th 2021, 1:00pm

Article

The addition of a novel drug to the chemotherapies gemcitabine and cisplatin significantly improved a survival outcome in patients with a rare form of head and neck cancer, compared with chemotherapy alone.

Addition of Chemo After Chemoradiation Fails to Improve Survival in Locally Advanced Cervical Cancer

June 4th 2021, 8:00pm

Article

Treatment with chemotherapy following the standard chemoradiation treatment failed to improve multiple survival outcomes in women with locally advanced cervical cancer.

Investigational Therapy Significantly Improves Survival in Patients with Prostate Cancer

June 4th 2021, 5:00pm

Article

The addition of an investigational therapy to standard-of-care treatment was associated with a median overall survival of 15.3 months in patients with progressive PSMA-positive metastatic castration-resistant prostate cancer.

Increased Screening Associated with Improved Outcomes in Younger Black Patients with Prostate Cancer

May 21st 2021, 6:00pm

Article

The study results lend strength to discuss prostate cancer screening in younger Black men, according to an expert.

Tecentriq Significantly Improves Survival Outcome in Patients with Early-Stage Non-Small Cell Lung Cancer

May 21st 2021, 1:00pm

Article

The data, according to an expert, show that treatment with Tecentriq could delay disease progression to an advanced stage, as well as the need for more aggressive therapy.

‘Great Deal of Work’ Still Needed to Reverse Increasing Rates of Several HPV-Related Cancers

May 20th 2021, 6:00pm

Article

Almost 20 years of data indicate that the incidence of HPV-related cervical cancer is noticeably declining, however other cancers related to the virus continue, and are expected, to increase.

Long-Term Cancer Survival May Be Worse in States With Lower Medicaid Eligibility Limits

May 19th 2021, 9:01pm

Article

Survival rates in this study were similar across cancer types including colorectal and prostate cancers, which may indicate a need for updated policies to include more patients.

Newly Diagnosed? One Cancer Expert Offers Her Advice

August 5th 2019, 9:19pm

Article

The executive director of the Cancer Policy Institute at the Cancer Support Community offers some candid advice for individuals who may be facing a new cancer diagnosis.

Merger of Two Groups Boosts Psychosocial Support Resources for Patients With Cancer

July 29th 2019, 6:05pm

Article

The merging of MyLifeLine.org with Cancer Support Community facilitates more comprehensive social and emotional support for patients and caregivers affected by cancer.

Updated Analysis Supports Evaluation of Second-Line Fedratinib to Treat Myelofibrosis

July 24th 2019, 1:00am

Article

Treatment with fedratinib may lead to clinically meaningful responses among patients with myelofibrosis who were previously treated with Jakafi, according to an updated analysis of the phase 2 JAKARTA2 study.